Journal of Clinical Biochemistry and Nutrition
Online ISSN : 1880-5086
Print ISSN : 0912-0009
ISSN-L : 0912-0009
Original Articles
Advanced Glycation Endproducts Act as An Initiator of Skin Tumors in Mice
Masakazu OgataGoji HasegawaNaoto NakamuraHiroshi ObayashiToshikazu YoshikawaHoyoku NishinoHarukuni Tokuda
Author information
JOURNAL FREE ACCESS

2006 Volume 38 Issue 3 Pages 176-179

Details
Abstract

The role of advanced glycation endproducts (AGEs) as the initiator of tumor induction was investigated in SENCAR mice. Initiation with AGEs-modified bovine serum albumin (AGEs–BSA) increased both the incidence of tumor-bearing mice and the mean number of tumors per mouse. An immunohistochemical study revealed an increase in 8-hydroxy-2'-deoxyguanosine (8-OhdG) in nuclei of epidermal cells in the AGEs-BSA treated mice. Furthermore, a Salmonella mutagenicity test revealed that AGEs-BSA was mutagenic only in Salmonella TA104, a strain more sensitive to oxidative stress than other strains. These results suggest that AGEs are mutagenic through a mechanism associated with oxidative stress.

Content from these authors
© 2006 by The Editorial Secretariat of JCBN
Previous article Next article
feedback
Top